If you are interested in more information about a particular trial, please talk with your treating physician first, and they may contact this centre for further information if necessary.
|
Tumour Group / Site |
Trial Title |
Opening Date |
|---|
BREAST
| A Phase III, Multicenter, Randomized, Open-Label Trial To Evaluate Efficacy And Safety Of Ribociclib With Endocrine Therapy As An Adjuvant Treatment In Patients With Hormone Receptor-Positive, HER2-Negative, Early Breast Cancer (NATALEE)
| Jun 2019
|
GYNE
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy (ATHENA) | Feb 2019
|
H&N
| A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of Atezolizumab (Anti-Pd-L1 Antibody) As Adjuvant Therapy After Definitive Local Therapy In Patients With High‑Risk Locally Advanced Squamous Cell Carcinoma Of The Head And Neck. Protocol Wo40242 (IMvoke 010)
| Dec 2018
|
| GU | Androgen Suppression with Stereotactic Body or External Beam Radiation Therapy-A Phase II Randomized Trial for Intermediate and High Risk Prostate Cancer (ASSERT) | June 2016 |
|
Lung | A Phase 3 Prospective Double Blind Placebo Controlled Randomized Study of Adjuvant Medi4736 in Completely Resected Non-Small Cell Lung Cancer (CCTG BR.31) | Sept 2015 |
| Lung | A Phase II Randomized Study of Pembrolizumab in Patients with Advanced Malignant Pleural Mesothelioma (CCTG IND.227)
| Feb 2017 |
|
Lymphoma | Biology of Lymphoid Cancer
(Lymphoid Study) | Jan 2014 |
| Melanoma | A Randomized Phase III Study of Duration of Anti-PD-1 Therapy in Metastatic Melanoma (STOP-GAP) CCTG ME.13 |
July 2017
|
You can view a video on participating in clinical trials that was created by staff at BC Cancer's Fraser Valley Centre.
http://learn.phsa.ca/bcca/clinicaltrials/2012oct23/ClinicalTrials2012oct23_flv_loader.html
|
